Allogeneic Hematopoietic Stem Cell Transplantation With Ixazomib for High Risk Multiple Myeloma (BMT CTN 1302)
Clinical trial NCT02440464 · COMPLETED
Trial details
- NCT number
- NCT02440464
- Sponsor
- National Heart, Lung, and Blood Institute (NHLBI)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-01
- Primary completion
- 2020-10-01
- Enrollment
- 57
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.